PHARMAVEST ApS: Financial statements 2023
CVR: 26385180
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,975,235 and a net result of DKK 1,013,388 compared with DKK 680,459 the year before. That is an increase of 11.6% compared with the year before. Equity in the 2023 report amounted to DKK 5,745,582. The solvency ratio was 84%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,975,235
- Profit/Loss
- DKK 1,013,388
- Equity
- DKK 5,745,582
- Total Assets
- DKK 6,837,582
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2 mio. | 1 mio. | 5.7 mio. | 1 |
| 2022 | - | 1.8 mio. | 680 t. | 4.9 mio. | 1 |
| 2021 | - | 1.8 mio. | 618 t. | 4.3 mio. | 1 |
| 2020 | - | 1.2 mio. | 281 t. | 3.8 mio. | 1 |
| 2019 | - | 1.8 mio. | 818 t. | 3.6 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMAVEST ApS has published its annual report for 2022. Gross profit came to DKK 1,770,660, and the net result was DKK 680,459.
About PHARMAVEST ApS
PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.